Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
March 2026
The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy
RAPID SIMULTANEOUS DETECTION OF 22 RESPIRATORY PATHOGENS
, /in Featured Articles /by 3wmediayour partner in diagnosis
, /in Featured Articles /by 3wmediaHeart Attack & Stroke
, /in Featured Articles /by 3wmediaNew Agarose Gels
, /in Featured Articles /by 3wmediaVision Uri+
, /in Featured Articles /by 3wmediaFULL AUTOMATION – ELISA – IFA – BLOT – ELITE LINE
, /in Featured Articles /by 3wmediaGlycomat 3000
, /in Featured Articles /by 3wmediaKimes 2012
, /in Featured Articles /by 3wmediaMulti-Constituent Controls
, /in Featured Articles /by 3wmedia‘Getting to zero’: first the good news
, /in Featured Articles /by 3wmediaIt is thirty years since the first diagnoses of AIDS were reported, since when, according to the most recent UNAids report, 25 million people have died from HIV-related causes and around 34 million people are currently living with the virus. However, as we enter the fourth decade of this devastating pandemic, there is certainly some light at the end of the tunnel, reflected in the theme that was adopted for this year’s World AIDS Day and until 2015: ‘Getting to Zero’. Although more aspirational than achievable, very real progress has been made.
The good news is that the number of AIDS-related deaths last year was the lowest (1.8 million deaths) since the peak of 2.2 million deaths in 2005, predominantly because of increasing access to antiretroviral treatment (ART) in low- and middle-income countries where the disease burden is heaviest, and where nearly seven million people are now receiving appropriate therapy. The UN-backed Global Fund against AIDS, TB and Malaria has played a significant role in this achievement. The incidence of HIV has also fallen in 33 countries, two thirds of which are in sub-Saharan Africa. Not only has ART reduced transmission, including vertical transmission, of the virus, but education and condom provision, more widespread HIV testing even in low-resource settings and counselling if necessary have all had a large impact. While efforts to introduce an effective HIV vaccine continue to be disappointing, results from trials on the pre-exposure use of antiretrovirals for prophylaxis are encouraging, and more easily tolerated drugs, such as rilpivirine, will improve life for some patient groups.
So what is the bad news? Firstly in some Western countries, where infected people can be diagnosed and treated early and have a near-normal lifespan, the incidence of HIV is actually increasing. And more important globally, there are still around ten million people waiting for treatment, the number of people with new infections remains higher than the number of people starting ART, and the staunch efforts of the Global Fund may now be affected by the financial fraud which was exposed in four recipient countries earlier this year as well as by the global economic crisis. Last month it was revealed that whilst international donors (the principal donors are the US, Germany, France and Japan) have been asked for donations totalling around fifteen billion Euros, the Global Fund has received only eight and a half billion Euros, which is lower than the amount needed to maintain its current programmes for the next three years. It is indeed a tragedy if millions of people continue to suffer from HIV because of the greed and mismanagement of a powerful few.